Treatment of carotid stenosis

Current Vascular Pharmacology

Volumn 10, Issue 6, 2012, Pages 734-738

  Touzé, Emmanuel ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Atherosclerosis; Carotid stenosis; Prevention; Stroke

Indexed keywords

ANTITHROMBOCYTIC AGENT; ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; DISEASE SEVERITY; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; META ANALYSIS (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; TRANSCRANIAL DOPPLER;

AGED; AGED, 80 AND OVER; ANGIOPLASTY; ASYMPTOMATIC DISEASES; CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT SELECTION; PLATELET AGGREGATION INHIBITORS; RISK ASSESSMENT; RISK FACTORS; STENTS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84870213567     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/157016112803520800     Document Type: Article

References (23)

1. European Carotid Surgery Trialists's Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotis stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998; 351: 1379-87.
2. Barnett HJM, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998; 339: 1415-25.
3. de Weerd M, Greving JP, Hedblad B, et al. Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-analysis. Stroke 2010; 41: 1294-7.
4. Wolff T, Guirguis-Blake J, Miller T, Gillespie M, Harris R. Screening for carotid artery stenosis: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2007; 147: 860-70.
5. Touzé E. Natural history of asymptomatic carotid artery stenosis. RevNeurol(Paris) 2008; 164: 793-800.
6. Touzé E, Varenne O, Chatellier G, Peyrard S, Rothwell PM, Mas JL. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and metaanalysis. Stroke 2005; 36: 2748-55.
7. Touzé E, Warlow CP, Rothwell PM. Risk of coronary and other non-stroke vascular death in relation to the presence and extent of atherosclerotic disease at the carotid bifurcation. Stroke 2006; 37: 2904-9.
8. Abbott AL. Medical (non-surgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke 2009; 40: e573-83.
9. Pickett CA, Jackson JL, Hemann BA, Atwood JE. Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: a meta-analysis. Lancet 2008; 371: 1587-94.
10. Calvet D, Touzé E, Varenne O, Sablayrolles JL, Weber S, Mas JL. Prevalence of asymptomatic coronary artery disease in ischemic stroke patients: the PRECORIS study. Circulation 2010; 121: 1623-9.
11. Heart Protection Study Collaborative Group. Effects of cholesterollowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other highrisk conditions. Lancet 2004; 363: 757-67.
12. Sillesen H, Amarenco P, Hennerici MG, et al. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2008; 39: 3297-302.
13. Halliday A, Harrison M, Hayter E, et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet 2010; 376: 1074-84.
14. Markus HS, King A, Shipley M, et al. Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. Lancet Neurol 2010; 9: 663-71.
15. Turc G, Oppenheim C, Naggara O, et al. Relationships between recent intraplaque hemorrhage and stroke risk factors in patients with carotid stenosis: The HIRISC Study. Arterioscler Thromb Vasc Biol 2012 (in press).
16. Brott TG, Hobson RW, 2nd, Howard G, et al. Stenting vs. endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010; 363: 11-23.
17. Rothwell PM. Medical and surgical management of symptomatic carotid stenosis. Int J Stroke 2006; 1: 140-9.
18. Rothwell PM, Eliasziw M, Gutnikov SA, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361: 107-16.
19. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363: 915-24.
20. Bonati LH, Dobson J, Algra A, et al. Short-term outcome after stenting vs. endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data. Lancet 2010; 376: 1062-73.
21. Naggara O, Touzé E, Beyssen B, et al. Anatomical and technical factors associated with stroke or death during carotid angioplasty and stenting: results from the endarterectomy vs. angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial and systematic review. Stroke 2011; 42: 380-8.
22. Touzé E, Trinquart L, Chatellier G, Mas JL. Systematic review of the perioperative risks of stroke or death after carotid angioplasty and stenting. Stroke 2009; 40: e683-93.
23. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995; 273: 1421-8.